Premorbid obesity, but not nutrition, prevents critical illness‐induced muscle wasting and weakness

The ‘obesity paradox’ of critical illness refers to better survival with a higher body mass index. We hypothesized that fat mobilized from excess adipose tissue during critical illness provides energy more efficiently than exogenous macronutrients and could prevent lean tissue wasting.

[1]  M. Luedi.  Journal of Cachexia, Sarcopenia and Muscle , 2019 .

[2]  C. Hough,et al.  ICU-Acquired Weakness. , 2016, Chest.

[3]  S. Anker,et al.  Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015 , 2015, Journal of cachexia, sarcopenia and muscle.

[4]  Rahul Phadke,et al.  Qualitative Ultrasound in Acute Critical Illness Muscle Wasting , 2015, Critical care medicine.

[5]  F. Azizi,et al.  Obesity Paradox and Risk of Mortality Events in Chronic Kidney Disease Patients: A Decade of Follow-up in Tehran Lipid and Glucose Study. , 2015, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[6]  M. Singer,et al.  Detailed Characterization of a Long-Term Rodent Model of Critical Illness and Recovery , 2015, Critical care medicine.

[7]  G. Van den Berghe,et al.  Metabolic and nutritional support of critically ill patients: consensus and controversies , 2015, Critical Care.

[8]  R. Deckelbaum,et al.  In vivo handling and metabolism of lipid emulsions. , 2015, World review of nutrition and dietetics.

[9]  W. Chan,et al.  Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. , 2014, Journal of the American College of Cardiology.

[10]  R. Powers,et al.  Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia , 2014, Cancer & metabolism.

[11]  Avinash B. Kumar,et al.  Obesity and perioperative acute kidney injury: a focused review. , 2014, Journal of critical care.

[12]  C. Lavie,et al.  Obesity paradox, cachexia, frailty, and heart failure. , 2014, Heart failure clinics.

[13]  S. von Haehling.  ICU-acquired weakness and recovery from critical illness. , 2014, The New England journal of medicine.

[14]  James A. Nathan,et al.  Muscle wasting in disease: molecular mechanisms and promising therapies , 2014, Nature Reviews Drug Discovery.

[15]  Laura Antanas,et al.  Charisma: An integrated approach to automatic H&E-stained skeletal muscle cell segmentation using supervised learning and novel robust clump splitting , 2013, Medical Image Anal..

[16]  Rahul Phadke,et al.  Acute skeletal muscle wasting in critical illness. , 2013, JAMA.

[17]  G. Van den Berghe,et al.  Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. , 2013, The Lancet. Respiratory medicine.

[18]  G. Van den Berghe,et al.  Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages , 2013, Critical Care.

[19]  Niels Peek,et al.  Body Mass Index Is Associated With Hospital Mortality in Critically Ill Patients: An Observational Cohort Study , 2013, Critical care medicine.

[20]  Dina Demner-Fushman,et al.  Lower short- and long-term mortality associated with overweight and obesity in a large cohort study of adult intensive care unit patients , 2012, Critical Care.

[21]  A. Molina,et al.  Catabolic Signaling Pathways, Atrogenes, and Ubiquitinated Proteins Are Regulated by the Nutritional Status in the Muscle of the Fine Flounder , 2012, PloS one.

[22]  G. Van den Berghe,et al.  Early parenteral nutrition evokes a phenotype of autophagy deficiency in liver and skeletal muscle of critically ill rabbits. , 2012, Endocrinology.

[23]  J. Wernerman,et al.  Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis. , 2012, Clinical science.

[24]  Sarah Derde,et al.  Muscle atrophy and preferential loss of myosin in prolonged critically ill patients* , 2012, Critical care medicine.

[25]  G. Van den Berghe,et al.  Early versus Late Parenteral Nutrition in Critically Ill Adults , 2011, The New England journal of medicine.

[26]  J. Schefold,et al.  Intensive care unit—acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock , 2010, Journal of cachexia, sarcopenia and muscle.

[27]  Z. Puthucheary,et al.  Skeletal muscle dysfunction in critical care: Wasting, weakness, and rehabilitation strategies , 2010, Critical care medicine.

[28]  Raphaël Porcher,et al.  Propensity scores in intensive care and anaesthesiology literature: a systematic review , 2010, Intensive Care Medicine.

[29]  R. Griffiths,et al.  Intensive care unit-acquired weakness , 2010, Critical care medicine.

[30]  G. Van den Berghe,et al.  Increasing intravenous glucose load in the presence of normoglycemia: Effect on outcome and metabolism in critically ill rabbits , 2010, Critical care medicine.

[31]  P. Pronovost,et al.  The impact of obesity on outcomes after critical illness: a meta-analysis , 2009, Intensive Care Medicine.

[32]  Md. Razaul Karim,et al.  Cytosolic LC3 ratio as a quantitative index of macroautophagy. , 2009, Methods in enzymology.

[33]  A. E. El Solh,et al.  Effect of obesity on intensive care morbidity and mortality: A meta-analysis* , 2008, Critical care medicine.

[34]  Masaaki Komatsu,et al.  Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice , 2007, Cell.

[35]  P. Pronovost,et al.  Neuromuscular dysfunction acquired in critical illness: a systematic review , 2007, Intensive Care Medicine.

[36]  G. Fonarow,et al.  An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. , 2007, American heart journal.

[37]  Sandra L. Peake,et al.  The effect of obesity on 12-month survival following admission to intensive care: A prospective study* , 2006, Critical care medicine.

[38]  I. Vanhorebeek,et al.  Endocrine aspects of acute and prolonged critical illness , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[39]  Ilse Vanhorebeek,et al.  Intensive insulin therapy protects the endothelium of critically ill patients. , 2005, The Journal of clinical investigation.

[40]  G. Van den Berghe,et al.  Hormonal and metabolic strategies to attenuate catabolism in critically ill patients. , 2004, Current opinion in pharmacology.

[41]  J. Horton,et al.  Molecular mediators of hepatic steatosis and liver injury. , 2004, The Journal of clinical investigation.

[42]  V. P. Misra,et al.  Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness* , 2003, Critical care medicine.

[43]  A. Goldberg,et al.  Patterns of gene expression in atrophying skeletal muscles: response to food deprivation , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  A. Bach,et al.  Structure and metabolic fate of triacylglycerol- and phospholipid-rich particles of commercial parenteral fat emulsions. , 1999, Nutrition.

[45]  H. Phetteplace,et al.  Sepsis-induced regulation of lipoprotein lipase expression in rat adipose tissue and soleus muscle. , 1997, Journal of lipid research.

[46]  J. Rodin,et al.  Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. , 1995, Metabolism: clinical and experimental.

[47]  L. Chan,et al.  Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level. , 1993, Journal of lipid research.

[48]  M. Ulmer,et al.  Paradoxical effect of ethanol on liver lipogenesis in the genetically-obese Zucker rat , 1985, British Journal of Nutrition.

[49]  S H Rosenbaum,et al.  Influence of total parenteral nutrition on fuel utilization in injury and sepsis. , 1980, Annals of surgery.

[50]  D. Williamson,et al.  Physiological roles of ketone bodies as substrates and signals in mammalian tissues. , 1980, Physiological reviews.

[51]  P. Björntorp,et al.  Plasma free fatty acid turnover rate in obesity. , 2009, Acta medica Scandinavica.